AVANOS MEDICAL, INC.
AVNSAvanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
1 upcoming, 1 past
AVNS Earnings Report
EPS Est: $0.22 | FQ end 2026-06
How AVNS's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is AVANOS MEDICAL, INC.'s next FDA catalyst?→
AVANOS MEDICAL, INC.'s (AVNS) next tracked catalyst is a Acquisition expected August 2, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track AVNS biotech catalysts?→
Add AVNS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow AVANOS MEDICAL, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.